In reality, we'll be lucky if one of these treatments ever makes it. That's so crushingly depressing to mentally acknowledge and type out, but there you go.
It doesn't matter how awesome the solution is if the company doesn't have the finances to get the product through trials and to market release. We all need to recognise the fact that any of these treatments in the pipeline could vanish like Aderans did.
It doesn't matter how awesome the solution is if the company doesn't have the finances to get the product through trials and to market release. We all need to recognise the fact that any of these treatments in the pipeline could vanish like Aderans did.
Stratus has suspended development of its past businesses, including ProElite, and, contingent on sufficient capital, is seeking acquisitions. On October 4, 2013, the Company and Histogen, Inc. ("Histogen") executed a non-binding letter of intent pursuant to which the Company agreed to acquire all of the capital stock of Histogen for 350,000,000 pre-reverse split shares of the Company's common stock. Discussions regarding this potential acquisition have halted and the Company does not intend to further pursue this potential acquisition.
Oh No! RestoreGeneX isn't gonna happen?...man, Histogen is such a better solution to Minoxidil. Two treatments and you wont have to worry about hairloss progression for at least 12 months!
What is wrong with investors??? Histogen will kill Regaine within months!!!
Stratus has suspended development of its past businesses, including ProElite, and, contingent on sufficient capital, is seeking acquisitions. On October 4, 2013, the Company and Histogen, Inc. ("Histogen") executed a non-binding letter of intent pursuant to which the Company agreed to acquire all of the capital stock of Histogen for 350,000,000 pre-reverse split shares of the Company's common stock. Discussions regarding this potential acquisition have halted and the Company does not intend to further pursue this potential acquisition.
Whew. I was worried they bought Histogen and were going to shut it down.
But that's not what this says. This says that they have a non-binding (whew) agreement.
Whew!!!
It could mean anything.
It doesn't mean the Histogen solution is any less awesome
Stratus has suspended development of its past businesses, including ProElite, and, contingent on sufficient capital, is seeking acquisitions. On October 4, 2013, the Company and Histogen, Inc. ("Histogen") executed a non-binding letter of intent pursuant to which the Company agreed to acquire all of the capital stock of Histogen for 350,000,000 pre-reverse split shares of the Company's common stock. Discussions regarding this potential acquisition have halted and the Company does not intend to further pursue this potential acquisition.
Leave a comment: